Use the Back button in your browser to see the other results of your search or to select another record.
Detailed Search Results
| Metabolic and neurocognitive changes following lifestyle modification: examination of biomarkers from the ENLIGHTEN randomized clinical trial |
| Smith PJ, Mabe SM, Sherwood A, Doraiswamy PM, Welsh-Bohmer KA, Burke JR, Kraus WE, Lin PH, Browndyke JN, Babyak MA, Hinderliter AL, Blumenthal JA |
| Journal of Alzheimer's Disease 2020;77(4):1793-1803 |
| clinical trial |
| 5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
Copyright release for this abstract has not been granted.
|
The database was last updated on 3 February 2025 (this includes records added or amended since 2 December 2024). The next update is planned for 3 March 2025. The total number of records on the database is 64,098.